Literature DB >> 26551735

Anticipatory activation of the unfolded protein response by epidermal growth factor is required for immediate early gene expression and cell proliferation.

Liqun Yu1, Neal Andruska2, Xiaobin Zheng1, David J Shapiro3.   

Abstract

The onco-protein epidermal growth factor (EGF) initiates a cascade that includes activation of the ERK and AKT signaling pathways and alters gene expression. We describe a new action of EGF-EGF receptor (EGFR), rapid anticipatory activation of the endoplasmic reticulum stress sensor, the unfolded protein response (UPR). Within 2 min, EGF elicits EGFR dependent activation of phospholipase C γ (PLCγ), producing inositol triphosphate (IP3), which binds to IP3 receptor (IP3R), opening the endoplasmic reticulum IP3R Ca(2+) channels, resulting in increased intracellular Ca(2+). This calcium release leads to transient and moderate activation of the IRE1α and ATF6α arms of the UPR, resulting in induction of BiP chaperone. Knockdown or inhibition of EGFR, PLCγ or IP3R blocks the increase in intracellular Ca(2+). While blocking the increase in intracellular Ca(2+) by locking the IP3R calcium channel with 2-APB had no effect on EGF activation of the ERK or AKT signaling pathways, it abolished the rapid EGF-mediated induction and repression of gene expression. Knockdown of ATF6α or XBP1, which regulate UPR-induced chaperone production, inhibited EGF stimulated cell proliferation. Supporting biological relevance, increased levels of EGF receptor during tumor progression were correlated with increased expression of the UPR gene signature. Anticipatory activation of the UPR is a new role for EGF. Since UPR activation occurs in <2 min, it is an initial cell response when EGF binds EGFR.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Breast cancer; Calcium; Epidermal growth factor (EGF); Gene regulation; Unfolded protein response (UPR)

Mesh:

Substances:

Year:  2015        PMID: 26551735      PMCID: PMC4919024          DOI: 10.1016/j.mce.2015.11.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  64 in total

Review 1.  Consistency test of the cell cycle: roles for p53 and EGR1.

Authors:  Yaara Zwang; Moshe Oren; Yosef Yarden
Journal:  Cancer Res       Date:  2012-02-07       Impact factor: 12.701

Review 2.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

3.  Estrogen receptor α inhibitor activates the unfolded protein response, blocks protein synthesis, and induces tumor regression.

Authors:  Neal D Andruska; Xiaobin Zheng; Xujuan Yang; Chengjian Mao; Mathew M Cherian; Lily Mahapatra; William G Helferich; David J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

4.  Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.

Authors:  Steffan T Nawrocki; Jennifer S Carew; Kenneth Dunner; Lawrence H Boise; Paul J Chiao; Peng Huang; James L Abbruzzese; David J McConkey
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

5.  Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis.

Authors:  Masahiro Shuda; Nobuo Kondoh; Nobuo Imazeki; Kenji Tanaka; Tetsuya Okada; Kazutoshi Mori; Akiyuki Hada; Masaaki Arai; Toru Wakatsuki; Osamu Matsubara; Naoki Yamamoto; Mikio Yamamoto
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

6.  ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress.

Authors:  Jun Wu; D Thomas Rutkowski; Meghan Dubois; Jayanth Swathirajan; Thomas Saunders; Junying Wang; Benbo Song; Grace D-Y Yau; Randal J Kaufman
Journal:  Dev Cell       Date:  2007-09       Impact factor: 12.270

7.  XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response.

Authors:  Ann-Hwee Lee; Neal N Iwakoshi; Laurie H Glimcher
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  Ligand-independent activation of estrogen receptor alpha by XBP-1.

Authors:  Lihua Ding; Jinghua Yan; Jianhua Zhu; Hongjun Zhong; Qiujun Lu; Zonghua Wang; Cuifen Huang; Qinong Ye
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

9.  Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

Authors:  Michael J Lee; Albert S Ye; Alexandra K Gardino; Anne Margriet Heijink; Peter K Sorger; Gavin MacBeath; Michael B Yaffe
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

10.  EGFR amplification and lack of activating mutations in metaplastic breast carcinomas.

Authors:  J S Reis-Filho; C Pinheiro; M B K Lambros; F Milanezi; S Carvalho; K Savage; P T Simpson; C Jones; S Swift; A Mackay; R M Reis; J L Hornick; E M Pereira; F Baltazar; C D M Fletcher; A Ashworth; S R Lakhani; F C Schmitt
Journal:  J Pathol       Date:  2006-08       Impact factor: 7.996

View more
  17 in total

Review 1.  Anticipatory UPR Activation: A Protective Pathway and Target in Cancer.

Authors:  David J Shapiro; Mara Livezey; Liqun Yu; Xiaobin Zheng; Neal Andruska
Journal:  Trends Endocrinol Metab       Date:  2016-06-25       Impact factor: 12.015

2.  Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations.

Authors:  Liqun Yu; Lawrence Wang; Chengjian Mao; Darjan Duraki; Ji Eun Kim; Rui Huang; William G Helferich; Erik R Nelson; Ben Ho Park; David J Shapiro
Journal:  Cancer Lett       Date:  2018-11-09       Impact factor: 8.679

3.  Src couples estrogen receptor to the anticipatory unfolded protein response and regulates cancer cell fate under stress.

Authors:  Liqun Yu; Lawrence Wang; Ji Eun Kim; Chengjian Mao; David J Shapiro
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-06-02       Impact factor: 4.739

Review 4.  Interplay between steroid hormone activation of the unfolded protein response and nuclear receptor action.

Authors:  Xiaobin Zheng; Neal Andruska; Liqun Yu; Chengjian Mao; Ji Eun Kim; Mara Livezey; William G Helferich; David J Shapiro
Journal:  Steroids       Date:  2016-03-23       Impact factor: 2.668

5.  Nano-liquid Chromatography-orbitrap MS-based Quantitative Proteomics Reveals Differences Between the Mechanisms of Action of Carnosic Acid and Carnosol in Colon Cancer Cells.

Authors:  Alberto Valdés; Virginia García-Cañas; Konstantin A Artemenko; Carolina Simó; Jonas Bergquist; Alejandro Cifuentes
Journal:  Mol Cell Proteomics       Date:  2016-11-10       Impact factor: 5.911

6.  Spatial and temporal alterations in protein structure by EGF regulate cryptic cysteine oxidation.

Authors:  Jessica B Behring; Sjoerd van der Post; Arshag D Mooradian; Matthew J Egan; Maxwell I Zimmerman; Jenna L Clements; Gregory R Bowman; Jason M Held
Journal:  Sci Signal       Date:  2020-01-21       Impact factor: 8.192

7.  Strong and sustained activation of the anticipatory unfolded protein response induces necrotic cell death.

Authors:  Mara Livezey; Rui Huang; Paul J Hergenrother; David J Shapiro
Journal:  Cell Death Differ       Date:  2018-06-13       Impact factor: 15.828

8.  Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab.

Authors:  Chaonan Sun; Chuyang Han; Yuanjun Jiang; Ning Han; Miao Zhang; Guang Li; Qiao Qiao
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

9.  Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response.

Authors:  Xiaobin Zheng; Neal Andruska; Michael J Lambrecht; Sisi He; Amadeo Parissenti; Paul J Hergenrother; Erik R Nelson; David J Shapiro
Journal:  Oncotarget       Date:  2016-07-24

Review 10.  Targeting protein quality control pathways in breast cancer.

Authors:  Sara Sannino; Jeffrey L Brodsky
Journal:  BMC Biol       Date:  2017-11-16       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.